Literature DB >> 25224081

Drug/nondrug classification using Support Vector Machines with various feature selection strategies.

Selcuk Korkmaz1, Gokmen Zararsiz2, Dincer Goksuluk2.   

Abstract

In conjunction with the advance in computer technology, virtual screening of small molecules has been started to use in drug discovery. Since there are thousands of compounds in early-phase of drug discovery, a fast classification method, which can distinguish between active and inactive molecules, can be used for screening large compound collections. In this study, we used Support Vector Machines (SVM) for this type of classification task. SVM is a powerful classification tool that is becoming increasingly popular in various machine-learning applications. The data sets consist of 631 compounds for training set and 216 compounds for a separate test set. In data pre-processing step, the Pearson's correlation coefficient used as a filter to eliminate redundant features. After application of the correlation filter, a single SVM has been applied to this reduced data set. Moreover, we have investigated the performance of SVM with different feature selection strategies, including SVM-Recursive Feature Elimination, Wrapper Method and Subset Selection. All feature selection methods generally represent better performance than a single SVM while Subset Selection outperforms other feature selection methods. We have tested SVM as a classification tool in a real-life drug discovery problem and our results revealed that it could be a useful method for classification task in early-phase of drug discovery.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Keywords:  Drug discovery; Feature selection; Machine learning; Molecular descriptors; Support Vector Machines

Mesh:

Substances:

Year:  2014        PMID: 25224081     DOI: 10.1016/j.cmpb.2014.08.009

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  7 in total

1.  Distinguishing drug/non-drug-like small molecules in drug discovery using deep belief network.

Authors:  Seyed Aghil Hooshmand; Sadegh Azimzadeh Jamalkandi; Seyed Mehdi Alavi; Ali Masoudi-Nejad
Journal:  Mol Divers       Date:  2020-03-19       Impact factor: 2.943

2.  Influence of feature rankers in the construction of molecular activity prediction models.

Authors:  Gonzalo Cerruela-García; José Pérez-Parra Toledano; Aída de Haro-García; Nicolás García-Pedrajas
Journal:  J Comput Aided Mol Des       Date:  2019-12-31       Impact factor: 3.686

3.  Identification of potential inhibitors of Zika virus targeting NS3 helicase using molecular dynamics simulations and DFT studies.

Authors:  Shashank Shekher Mishra; Neeraj Kumar; Bidhu Bhusan Karkara; C S Sharma; Sourav Kalra
Journal:  Mol Divers       Date:  2022-09-05       Impact factor: 3.364

4.  MLViS: A Web Tool for Machine Learning-Based Virtual Screening in Early-Phase of Drug Discovery and Development.

Authors:  Selcuk Korkmaz; Gokmen Zararsiz; Dincer Goksuluk
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

5.  Clustering molecular dynamics trajectories for optimizing docking experiments.

Authors:  Renata De Paris; Christian V Quevedo; Duncan D Ruiz; Osmar Norberto de Souza; Rodrigo C Barros
Journal:  Comput Intell Neurosci       Date:  2015-03-22

6.  Discovery of Small-Molecule Activators for Glucose-6-Phosphate Dehydrogenase (G6PD) Using Machine Learning Approaches.

Authors:  Madhu Sudhana Saddala; Anton Lennikov; Hu Huang
Journal:  Int J Mol Sci       Date:  2020-02-23       Impact factor: 5.923

Review 7.  Machine Learning Methods in Drug Discovery.

Authors:  Lauv Patel; Tripti Shukla; Xiuzhen Huang; David W Ussery; Shanzhi Wang
Journal:  Molecules       Date:  2020-11-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.